Applied DNA Sciences Inc.

NASDAQ: APDN · Real-Time Price · USD
3.97
-0.10 (-2.46%)
At close: Aug 15, 2025, 12:13 PM

Applied DNA Sciences Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Revenue
3.43M 13.37M 18.17M 9.03M
Cost of Revenue
2.41M 7.83M 13.12M 4.1M
Gross Profit
1.02M 5.53M 5.05M 4.93M
Operating Income
-14.02M -10.95M -13.97M -12.29M
Interest Income
176.3K 75.33K 7.2K 13.68K
Pretax Income
-7.09M -10.02M -8.27M -14.28M
Net Income
-6.99M -9.95M -8.38M -16.03M
Selling & General & Admin
11.45M 12.75M 15.1M 12.61M
Research & Development
3.59M 3.74M 3.93M 3.77M
Other Expenses
n/a n/a n/a 844.44K
Operating Expenses
15.04M 16.49M 19.02M 17.22M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
17.46M 24.32M 32.14M 21.32M
Income Tax Expense
n/a n/a 107.94K 1.75M
Shares Outstanding (Basic)
3.97M 653.77K 448.38K 345.85K
Shares Outstanding (Diluted)
3.97M 653.77K 448.38K 345.85K
EPS (Basic)
-1.82 -15.21 -18.68 -46.35
EPS (Diluted)
-1.82 -15.21 -18.68 -46.35
EBITDA
-13.33M -9.59M -12.68M -11.68M
EBIT
-14.02M -10.95M -13.97M -12.53M
Depreciation & Amortization
696.42K 1.36M 1.29M 844.44K